Publikationen, an denen er mitarbeitet DANIEL MARTÍN IGLESIAS (11)
2024
-
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus
Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373
-
Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus
Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 15, pp. 2047-2060
-
Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm
International Journal of Rheumatic Diseases, Vol. 27, Núm. 4
-
Thrombotic antiphospholipid syndrome: From guidelines to clinical management
Medicina Clinica, Vol. 163, pp. S22-S30
-
Use of Glucocorticoids in SLE: A Clinical Approach
Mediterranean Journal of Rheumatology, Vol. 35, pp. 342-353
2023
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies
Seminars in Arthritis and Rheumatism, Vol. 59
2021
-
Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort
Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 249-257
-
Hydroxychloroquine Retinal Toxicity and Its Association with Dosage
The Journal of rheumatology
2020
-
Update on antimalarials and systemic lupus erythematosus
Current opinion in rheumatology, Vol. 32, Núm. 6, pp. 572-582